Long term mortality of patients with Parkinson's disease treated with deep brain stimulation in a reference center - ScienceDirect
Por um escritor misterioso
Descrição
Pimavanserin for patients with Parkinson's disease psychosis: a randomised, placebo-controlled phase 3 trial - The Lancet
The Therapeutic Potential of Hydroxycinnamic Acid Derivatives in Parkinson's Disease: Focus on In Vivo Research Advancements
Clinical outcome of deep brain stimulation for Parkinson's disease - ScienceDirect
Frontiers The mortality of patients with Parkinson's disease with deep brain stimulation
Parkinson's disease - ScienceDirect
Long term mortality of patients with Parkinson's disease treated with deep brain stimulation in a reference center - ScienceDirect
Parkinson's disease - The Lancet
Surgical treatment for Parkinson's disease - The Lancet Neurology
Integrated and patient-centred management of Parkinson's disease: a network model for reshaping chronic neurological care - The Lancet Neurology
Deep brain stimulation in neurological diseases and other pathologies
Deep brain stimulation: emerging indications - ScienceDirect
Parkinson's disease - ScienceDirect
de
por adulto (o preço varia de acordo com o tamanho do grupo)
